JPWO2023194525A5 - - Google Patents
Info
- Publication number
- JPWO2023194525A5 JPWO2023194525A5 JP2024559036A JP2024559036A JPWO2023194525A5 JP WO2023194525 A5 JPWO2023194525 A5 JP WO2023194525A5 JP 2024559036 A JP2024559036 A JP 2024559036A JP 2024559036 A JP2024559036 A JP 2024559036A JP WO2023194525 A5 JPWO2023194525 A5 JP WO2023194525A5
- Authority
- JP
- Japan
- Prior art keywords
- prostate cancer
- azd5305
- metastatic
- pharmaceutical product
- abiraterone acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263362614P | 2022-04-07 | 2022-04-07 | |
| US63/362,614 | 2022-04-07 | ||
| PCT/EP2023/059123 WO2023194525A1 (en) | 2022-04-07 | 2023-04-06 | Combination therapy for treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025511403A JP2025511403A (ja) | 2025-04-15 |
| JP2025511403A5 JP2025511403A5 (https=) | 2026-04-10 |
| JPWO2023194525A5 true JPWO2023194525A5 (https=) | 2026-04-10 |
Family
ID=86184958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559036A Pending JP2025511403A (ja) | 2022-04-07 | 2023-04-06 | 癌を治療するための併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250228847A1 (https=) |
| EP (1) | EP4504147A1 (https=) |
| JP (1) | JP2025511403A (https=) |
| KR (1) | KR20240170958A (https=) |
| CN (1) | CN118973555A (https=) |
| AU (1) | AU2023250030A1 (https=) |
| CA (1) | CA3254950A1 (https=) |
| IL (1) | IL316019A (https=) |
| MX (1) | MX2024012369A (https=) |
| TW (1) | TW202404592A (https=) |
| WO (1) | WO2023194525A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0705903B2 (en) | 1994-08-12 | 2009-08-12 | The University of Utah Research Foundation | Mutations in the 17q-linked breast and ovarian cancer susceptibility gene |
| DK0699754T3 (da) | 1994-08-12 | 2001-02-26 | Myriad Genetics Inc | Fremgangsmåde til diagnosticering af prædisposition for bryst- og ovariecancer |
| WO2018191141A1 (en) * | 2017-04-13 | 2018-10-18 | Janssen Pharmaceutica Nv | Combination therapy for prostate cancer |
| MX2022000711A (es) | 2019-07-19 | 2022-02-23 | Astrazeneca Ab | Inhibidores de parp1. |
| TW202228693A (zh) * | 2020-10-08 | 2022-08-01 | 瑞典商阿斯特捷利康公司 | 用於治療癌症之組合療法 |
-
2023
- 2023-04-06 WO PCT/EP2023/059123 patent/WO2023194525A1/en not_active Ceased
- 2023-04-06 IL IL316019A patent/IL316019A/en unknown
- 2023-04-06 KR KR1020247036945A patent/KR20240170958A/ko active Pending
- 2023-04-06 JP JP2024559036A patent/JP2025511403A/ja active Pending
- 2023-04-06 AU AU2023250030A patent/AU2023250030A1/en active Pending
- 2023-04-06 US US18/853,520 patent/US20250228847A1/en active Pending
- 2023-04-06 CN CN202380032506.8A patent/CN118973555A/zh active Pending
- 2023-04-06 EP EP23719306.5A patent/EP4504147A1/en active Pending
- 2023-04-06 CA CA3254950A patent/CA3254950A1/en active Pending
- 2023-04-07 TW TW112112998A patent/TW202404592A/zh unknown
-
2024
- 2024-10-04 MX MX2024012369A patent/MX2024012369A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024015120A5 (https=) | ||
| JP2022180461A5 (https=) | ||
| JP2023041862A5 (https=) | ||
| JP5890780B2 (ja) | 中枢を介する悪心および嘔吐を治療するための組成物および方法 | |
| CN106456626B (zh) | 喹啉衍生物用于治疗软组织肉瘤的方法和用途以及用于治疗软组织肉瘤的药物组合物 | |
| TW201210593A (en) | Compositions and methods for treating centrally mediated nausea and vomiting | |
| JP2020516646A5 (https=) | ||
| CN107872975A (zh) | 用于治疗恶心和呕吐的氨磺必利和其它止吐药的组合 | |
| IL320452A (en) | Combination therapy for prostate cancer | |
| US7705049B2 (en) | Methods for treating non-melanoma cancers with PABA | |
| TWI441639B (zh) | 用於治療卵巢癌之包含紫杉醇之組合 | |
| KR20010015918A (ko) | 안면홍조를 감소시키기 위한 플루옥세틴 히드로클로라이드 | |
| TW202539655A (zh) | Glp-1受體非肽促效劑化合物之口服投藥 | |
| JP2004525143A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| EP4494700A3 (en) | New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases | |
| JP2010504307A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| JP6370801B2 (ja) | 肝疾患または肝障害の治療のための使用および方法 | |
| CA2721728A1 (en) | Treatment of inflammatory bowel disease with 6-mercaptopurine | |
| JPWO2023194525A5 (https=) | ||
| JPWO2023194530A5 (https=) | ||
| JPWO2023194528A5 (https=) | ||
| CN120826242A (zh) | 抗cd20抗体药物偶联物在制备治疗套细胞淋巴瘤的药物中的用途 |